- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
A GP alleged a Celebrex journal ad implied guaranteed 100% pain relief. The Panel found the wording was…
Shire’s journal ad claimed Calcichew-D3 Forte was preferred over Adcal-D3 by 80% of patients and implied a pleasant…
Ferriprox banner and patient-newsletter content drew breaches for missing prescribing info link (HCP ad), unsubstantiated hanging comparison, and…
A BMJ Symbicort ad headed “Improving survival in COPD” was ruled misleading because it implied Symbicort improved survival,…
PMCPA case AUTH/2905/11/16 (Director v A Menarini). Completed 7 March 2017. Outcome: No breach; matter considered outwith the…
A Trelegy Ellipta web ad claimed “Improvement in quality of life vs ICS/LABA”. PMCPA ruled the comparison implied…
Napp was accused of off-licence renoprotection claims and missing renal dosing/adult-only info in an Invokana webcast ad. Panel…
LEO’s Protopic HCP webpage breached the Code for an image implying no need for sun precautions and for…
Gilead’s HIV.eu HCP site briefly remained accessible after “visit patient site” failed. Panel found promotional HCP content likely…
A P3 Pharmacy interview featuring Teva content was ruled promotional. The article lacked PI, AE reporting statement, certification…
One real case. One key lesson. Every week — free.